ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3067

Microscopic Colitis in Patients with Takayasu Arteritis; A Potential Association Between the Two Disease Entities

Nilufer Alpay Kanitez1, Bahtiyar Toz1, Mine Gulluoglu2, Burak Erer1,3, Murat Inanc4, Bilger Cavus5, Raim Iliaz5, Cetin Karaca5 and Sevil Kamali1, 1Department of Internal Medicine, Division of Rheumatology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, 2Pathology, Istanbul University, Istanbul Faculty of Medicine, İstanbul, Turkey, 3Department of Internal Medicine, Rheumatology Division, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, 4Department of Internal Medicine, Division of Rheumatology, Istanbul University, Istanbul Faculty of Medicine, İstanbul, Turkey, 5Department of Internal Medicine, Division of Gastroenterology, Istanbul University, Istanbul Faculty of Medicine, İstanbul, Turkey

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Takayasu arteritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Vasculitis Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Takayasu’s arteritis (TAK) is a chronic vasculitis of large-vessels, mainly affects the aorta and its branches in the middle-aged females. There are reports regarding the concurrence of inflammatory bowel disease (IBD) and TAK. Microscopic colitis (MC) has been demonstrated in inflammatory rheumatic diseases such as spondylarthropathies which has been linked to an ethiopathogenetical association between two diseases. MC as an IBD subgroup has not been investigated in TAK, so far. We aim to assess the presence of MC in TAK patients who have no clinically overt IBD symptoms.

Methods: We cross-sectionally assessed TAK patients, between the ages of 18-65, who were diagnosed according to ACR criteria. Disease activity was evaluated by Kerr’s criteria. Age and sex matched irritabl bowel syndrome (IBS) patients were selected as control group. Study subjects who have been on MC inducing medications, such as NSAIDs, PPI, anti-physchotic or anti-depressant and having co-morbidities were excluded. All patients and controls have been interviewed for IBD and IBS symptoms by the questionnaires of WHO guideline and Rome III criteria, respectively. Lower endoscopic procedure was performed with at least 5 random biopsies taken from different colonic segments and terminal ileum within the following 2 weeks after the research visit. A blinded expert pathologist evaluated the specimens for the thickness of the collagen band, the degree of inflammatory infiltration in the lamina propria, and the number of intraepithelial lymphocytes according to an algorythm proposed for MC assessment by Langner C et al.1. Lymphocytic and collagen colitis were defined as the subgroups of MC. Incomplete colitis has also been defined in the algorythm.

Results:

Thirty TAK patients (29 female) with the mean age of 35±11 (20-59), total disease duration of 107±79 months (3-286) and 10 female IBS controls with the mean age of 38±13 were included into the study. Type 2 vascular involvement was the most common (64%) pattern in the cohort. Nine of 30 (30%) TAK patients have active disease at the time of endoscopic procedure. MC was not demonstrated in any patients with IBS. All but one TAK patients had normal endoscopic findings. Erythema on the entire colonic mucosa as the only pathological endoscopic finding was demonstrated in one patient. The examination of terminal ileum was found  normal in both TAK and control groups. Three patients (10%) were full-filled LC criteria of MC. Incomplete LC was determined in additional 6 patients (20%). LC was found significantly higher among the patients with active TAK subgroup compared with inactive patients (p= 0.03, OR= 5,7).

Conclusion: MC was found significantly high in TAK patients who had no overt IBD symptoms/diagnosis. This preliminary report from this ongoing study supports that this association might have a pathopyhsiological relevance.


Disclosure: N. Alpay Kanitez, None; B. Toz, None; M. Gulluoglu, None; B. Erer, None; M. Inanc, None; B. Cavus, None; R. Iliaz, None; C. Karaca, None; S. Kamali, None.

To cite this abstract in AMA style:

Alpay Kanitez N, Toz B, Gulluoglu M, Erer B, Inanc M, Cavus B, Iliaz R, Karaca C, Kamali S. Microscopic Colitis in Patients with Takayasu Arteritis; A Potential Association Between the Two Disease Entities [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/microscopic-colitis-in-patients-with-takayasu-arteritis-a-potential-association-between-the-two-disease-entities/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/microscopic-colitis-in-patients-with-takayasu-arteritis-a-potential-association-between-the-two-disease-entities/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology